Obesity First: Addressing the Causes & Consequences of Obesity

Time: 9:00 am
day: Day One


  • Targeting obesity: leveraging a novel GIPR antagonist and GLP-1 receptor agonist to achieve significant reduction in body weight
  • How do we maintain optionality in obesity drug development?
  • Adapting to evolving needs on patient-centred obesity care